Inactief instrument

Andere talen MYnd Analytics Inc Nasdaq

Aandelen

US62857N2027

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Emmaus Life Sciences : Certificate of Incorporation/Bylaws - Form 8-K	28/05
Emmaus Life Sciences Reports Delayed Filing of Annual Report	15/04
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico	02/02
Emmaus Life Sciences, Inc. Receives Marketing Authorization from the Puerto Rico Department of Health for Endari® (L-Glutamine Oral Powder)	02/02
Emmaus Life Sciences : Material Agreement - Form 8-K	20/12
Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q3 Revenue $5M	14/11
Emmaus Life Sciences Reports Q3 2023 Financial Results	14/11
Emmaus Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Emmaus Life Sciences, Inc. Announces Board Changes	04-10-23
Emmaus Life Sciences Reports Management Changes	23-08-23
Emmaus Life Sciences, Inc. Announces Yutaka Niihara No Longer Serve as Chief Executive Officer	23-08-23
Emmaus Life Sciences, Inc. Announces Management Changes	23-08-23
Emmaus Life Sciences Reports Q2 2023 Financial Results	14-08-23
Emmaus Life Sciences : Reports Q2 2023 Financial Results - Form 8-K	14-08-23
Emmaus Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman	13-07-23
Emmaus Life Sciences, Inc Receives Marketing Authorization for EndariÂ® in Oman	13-07-23
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA	31-05-23
Emmaus Life Sciences, Inc. Receives Medicine Registration Certificate from the Bahrain National Health Regulatory Authority	31-05-23
Emmaus Life Sciences, Inc. Receives Medicine Registration Certificate from the Bahrain National Health Regulatory Authority	31-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen MYnd Analytics Inc Nasdaq

Aandelen

US62857N2027

Andere talen

Filters